Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome
about
Platelets in Pulmonary Immune Responses and Inflammatory Lung DiseasesThe Inflammatory Role of Platelets via Their TLRs and Siglec ReceptorsEmerging roles for platelets as immune and inflammatory cellsAdvances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infectionCapture of lipopolysaccharide (endotoxin) by the blood clot: a comparative studyInflammasome in platelets: allying coagulation and inflammation in infectious and sterile diseases?Down-regulation of platelet surface CD47 expression in Escherichia coli O157:H7 infection-induced thrombocytopeniaHaemolytic uraemic syndrome.Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7.ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpuraLipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway.Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome.Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease.Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome.Shiga toxin pathogenesis: kidney complications and renal failure.Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed.The role of calpain-myosin 9-Rab7b pathway in mediating the expression of Toll-like receptor 4 in platelets: a novel mechanism involved in α-granules trafficking.Expression and functionality of Toll-like receptor 3 in the megakaryocytic lineage.Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome.Association of haemolytic uraemic syndrome with dysregulation of chemokine receptor expression in circulating monocytes.Escherichia coli induces platelet aggregation in an FcγRIIa-dependent manner.Effects of Suilysin on Streptococcus suis-Induced Platelet Aggregation.Lipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2Calpain activity and Toll-like receptor 4 expression in platelet regulate haemostatic situation in patients undergoing cardiac surgery and coagulation in mice.Platelets as immune mediators: their role in host defense responses and sepsisToll-like receptor 4 regulates platelet function and contributes to coagulation abnormality and organ injury in hemorrhagic shock and resuscitation.Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue.Regulatory effects of TLR2 on megakaryocytic cell function.Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuumPlatelets and infections - complex interactions with bacteria.A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesiclesPlatelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobinToll-Like Receptor Signalling Is Not Involved in Platelet Response to Streptococcus pneumoniae In Vitro or In Vivo.Platelets as cellular effectors of inflammation in vascular diseases.Lipopolysaccharide stimulates platelets through an IL-1β autocrine loop.The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes.The thrombotic potential of oral pathogens.Platelet transfusion - the new immunology of an old therapy.The expanding field of platelet-bacterial interconnections.Platelet interaction with bacterial toxins and secreted products.
P2860
Q26739670-42DCAB12-8734-4FCD-B5E0-B544CC28ECAAQ27004467-89E78635-071F-4F59-8B80-09454AB20AD3Q27016553-5B7D3C73-1F59-4ECE-8688-BE2765D453CDQ27026551-CD6A75AA-CEE7-47D6-B035-1455E7FDF696Q27302075-45F926FB-8A07-499F-AEB8-03DBE682E08AQ27692706-4F089783-DDAA-46D1-BFE5-E770FA5BBA18Q28390993-2C3A47FF-CBE7-4464-91FF-7B687B71F080Q30244707-CDD335A3-DE79-4AFA-B247-6508A9DEEF5BQ30439707-B63AE1DF-3EF3-40BA-B157-1DC210CF521FQ33373698-167F9AE3-859C-4622-9F0E-B69977D249F1Q33384817-CC384500-27CA-4402-A8C8-7C46503333EBQ33386199-53DB57D1-5EFA-44EE-92E6-DA78607052BDQ33394010-6FAABB51-2877-4D83-8BC6-691146240AB1Q33397459-7B3648E2-F11C-4766-8951-2E90562951F2Q33397541-48BEBF59-F7AE-4B67-8E22-7D6CE6DE2233Q33404149-DE99A71C-A4B9-4FE8-BEAD-E54B753F2B77Q33413094-5C75294F-801D-4949-9F01-52969A37BF92Q33419814-26C71DC7-48F1-46DF-B4CA-9F2B8DCA04A6Q33420374-5AB0C9F2-C9ED-483E-AA71-5491F043E616Q33420958-FE19B14A-FC39-4D9B-849D-189D634E050BQ33428410-EFF57A31-6C85-4BB4-A7B3-50013C57C033Q33436437-3629557B-6DE5-459F-AC22-0B445E3C43D5Q33952458-5227477C-CDD2-4A7D-9DF0-D871E59E8810Q34204639-62D4A89D-F2C0-410F-A1D7-8F7BFA108666Q34590168-B8CDA174-1988-4077-AF92-5BE3415E14B9Q34734986-B4D5F971-AD7E-4845-B304-326A1CEB9F27Q34889826-6EF7B491-9478-49F5-B544-0A3A12A982E2Q35037420-CF4A10B3-08E4-4AC1-950D-0CCFC0A17278Q35101184-BF39F3CB-3066-4E54-B887-8A45A6B0ED88Q35124418-F389CCD1-B36A-4754-8B31-55C3588AA5C3Q35125841-786624B8-364D-44AC-9839-8AA4DFFFF2E3Q35990633-53612176-3818-464E-B632-3653CACF757AQ36038084-E32055FC-E9A5-4F73-B4D7-01486739D59AQ37081746-C64E36BB-590B-4C8C-8DDD-89D9517162EEQ37281999-380D0E73-5FFE-45AF-A77E-A89765B1BB48Q37640684-A265D1A7-104E-4EEE-AF23-3D10D56DD864Q37869349-60BF2D13-8DBA-4BB2-881A-1161BF941233Q38362628-3FD5DF5E-2FFF-4024-A327-379943A871ABQ38367124-CBB50154-7EA4-411E-867B-2C1F2603BD20Q38390429-A3C3BE5B-B5F8-475D-8EA1-8E8E2D3E7450
P2860
Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Lipopolysaccharide from entero ...... with hemolytic uremic syndrome
@ast
Lipopolysaccharide from entero ...... with hemolytic uremic syndrome
@en
Lipopolysaccharide from entero ...... with hemolytic uremic syndrome
@en-gb
Lipopolysaccharide from entero ...... with hemolytic uremic syndrome
@nl
type
label
Lipopolysaccharide from entero ...... with hemolytic uremic syndrome
@ast
Lipopolysaccharide from entero ...... with hemolytic uremic syndrome
@en
Lipopolysaccharide from entero ...... with hemolytic uremic syndrome
@en-gb
Lipopolysaccharide from entero ...... with hemolytic uremic syndrome
@nl
prefLabel
Lipopolysaccharide from entero ...... with hemolytic uremic syndrome
@ast
Lipopolysaccharide from entero ...... with hemolytic uremic syndrome
@en
Lipopolysaccharide from entero ...... with hemolytic uremic syndrome
@en-gb
Lipopolysaccharide from entero ...... with hemolytic uremic syndrome
@nl
P2093
P2860
P921
P3181
P1433
P1476
Lipopolysaccharide from entero ...... with hemolytic uremic syndrome
@en
P2093
Anne-lie Ståhl
Catharina Svanborg
Jody C Mooney
Majlis Svensson
Matthias Mörgelin
Phillip I Tarr
Roger Johnson
Sandra L Watkins
P2860
P304
P3181
P356
10.1182/BLOOD-2005-08-3219
P407
P5008
P577
2006-03-02T00:00:00Z